Promising Clinical Data on Gen-Probe's APTIMA(R) HPV Test Presented at Major European Medical Meeting
San Diego, November 21 (ots/PRNewswire) - - New, CE-Marked Molecular Assay May Help Identify Women with Cervical Cancer or Pre-Cancer More Accurately than Competing Technologies, Studies Show - Gen-Probe's (Nasdaq: GPRO) CE-marked APTIMA(R) HPV assay may be an important new molecular tool to more ...
mehr